A Prospective, Open-label, Randomized Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic Ethnicity.
Phase of Trial: Phase IV
Latest Information Update: 23 Oct 2015
At a glance
- Drugs Ciclosporin (Primary) ; Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 24 Sep 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 29 Sep 2009 New trial record